PFIZER INC (PFE) Shareholder Equity
- 2026-06-28: Common Stock, Value, IssuedUSD $482.00M; Additional Paid in CapitalUSD $95.03B; Treasury Stock, Common, ValueUSD $115.19B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-7.22B.
- 2026-03-29: Common Stock, Value, IssuedUSD $482.00M; Additional Paid in CapitalUSD $94.77B; Treasury Stock, Common, ValueUSD $115.19B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-7.20B.
- 2025-12-31: Common Stock, Value, IssuedUSD $481.00M; Additional Paid in CapitalUSD $94.47B; Treasury Stock, Common, ValueUSD $115.02B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-8.07B.
- 2025-09-28: Common Stock, Value, IssuedUSD $481.00M; Additional Paid in CapitalUSD $94.25B; Treasury Stock, Common, ValueUSD $115.01B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-8.07B.
PFIZER INC Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | Treasury Stock, Shares, Acquired shares | Preferred Stock, Value, Issued USD | Treasury Stock, Value USD | Noncontrolling Interest, Increase from Sale of Parent Equity Interest USD | Noncontrolling Interest, Decrease from Deconsolidation USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | $482.00M | $95.03B | $115.19B | $-7.22B | $112.09B | $85.19B | $85.49B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-29 | $482.00M | $94.77B | $115.19B | $-7.20B | $117.24B | $90.10B | $90.40B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $481.00M | $94.47B | $115.02B | $-8.07B | $114.61B | $86.48B | $86.78B | 3.94B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-28 | $481.00M | $94.25B | $115.01B | $-8.07B | $121.15B | $92.80B | $93.10B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-29 | $481.00M | $94.05B | $115.01B | $-8.44B | $117.61B | $88.69B | $89.01B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-30 | $481.00M | $93.86B | $115.01B | $-8.58B | $119.59B | $90.34B | $90.64B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $480.00M | $93.60B | $114.76B | $-7.84B | $116.72B | $88.20B | $88.50B | 3.93B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-29 | $480.00M | $93.48B | $114.76B | $-7.97B | $121.06B | $92.29B | $92.56B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $480.00M | $93.20B | $114.76B | $-7.82B | $116.60B | $87.70B | $87.97B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $480.00M | $93.00B | (m) | $-7.76B | $121.32B | $92.28B | $92.56B | (m) | (m) | (m) | (m) | $114.75B | (m) | (m) | (m) |
| 2023-12-31 | $478.00M | $92.63B | $114.49B | $-7.96B | $118.35B | $89.01B | $89.29B | 3.92B | (m) | (m) | $0.00 | $114.49B | (m) | (m) | (m) |
| 2023-10-01 | $478.00M | $92.50B | (m) | $-7.97B | $126.41B | $96.93B | $97.20B | (m) | (m) | (m) | (m) | $114.48B | (m) | (m) | (m) |
| 2023-07-02 | $478.00M | $92.33B | (m) | $-8.10B | $128.80B | $99.02B | $99.29B | (m) | (m) | (m) | (m) | $114.48B | (m) | (m) | (m) |
| 2023-04-02 | $478.00M | $92.15B | (m) | $-8.29B | $131.10B | $100.97B | $101.24B | (m) | (m) | (m) | (m) | $114.47B | (m) | (m) | (m) |
| 2022-12-31 | $476.00M | $91.80B | (m) | $-8.30B | $125.66B | $95.66B | $95.92B | 3.90B | 12 month · $2.00B | 12 month · 39.00M | $0.00 | $113.97B | (m) | (m) | 3.90B |
| 2022-10-02 | $476.00M | $91.36B | (m) | $-8.22B | $122.97B | $92.63B | $92.89B | (m) | 3 month · $0.00 9 month · $2.00B | (m) | (m) | $113.94B | (m) | (m) | (m) |
| 2022-07-03 | $476.00M | $91.18B | (m) | $-7.12B | $116.61B | $87.21B | $87.47B | (m) | 3 month · $0.00 6 month · $2.00B | (m) | (m) | $113.94B | (m) | (m) | (m) |
| 2022-04-03 | $476.00M | $90.84B | (m) | $-6.16B | $111.19B | $82.42B | $82.69B | (m) | 3 month · $2.00B | 3 month · 39.00M | (m) | $113.93B | (m) | (m) | (m) |
| 2021-12-31 | $473.00M | $90.59B | (m) | $-5.90B | $103.39B | $77.20B | $77.46B | (m) | 12 month · $0.00 | 12 month · 0.00 | $0.00 | $111.36B | (m) | (m) | 3.85B |
| 2021-10-03 | $473.00M | $89.97B | (m) | $-5.65B | $102.25B | $75.69B | $75.97B | (m) | 3 month · $0.00 9 month · $0.00 | (m) | (m) | $111.36B | (m) | (m) | (m) |
| 2021-07-04 | $472.00M | $89.34B | (m) | $-4.76B | $96.35B | $70.04B | $70.31B | (m) | 3 month · $0.00 6 month · $0.00 | (m) | (m) | $111.36B | (m) | (m) | (m) |
| 2021-04-04 | $472.00M | $89.00B | (m) | $-4.66B | $95.16B | $68.62B | $68.86B | (m) | 3 month · $0.00 | (m) | (m) | $111.35B | (m) | (m) | (m) |
| 2020-12-31 | $470.00M | $88.67B | (m) | $-5.31B | $90.39B | $63.24B | $63.47B | (m) | 12 month · $0.00 | 12 month · 0.00 | $0.00 | $110.99B | (m) | (m) | 3.84B |
| 2020-09-27 | $470.00M | $88.16B | (m) | $-12.68B | $100.28B | $65.26B | $65.50B | (m) | 3 month · $0.00 9 month · $0.00 | (m) | $0.00 | $110.98B | (m) | (m) | (m) |
| 2020-06-28 | $470.00M | $87.89B | (m) | $-13.25B | $100.20B | $64.34B | $64.57B | (m) | 3 month · $0.00 6 month · $0.00 | (m) | $0.00 | $110.98B | (m) | (m) | (m) |
| 2020-03-29 | $470.00M | $87.68B | (m) | $-13.13B | $101.00B | $65.03B | $65.34B | (m) | 3 month · $0.00 | (m) | $17.00M | $111.01B | (m) | (m) | (m) |
| 2019-12-31 | $468.00M | $87.43B | (m) | $-11.64B | $97.67B | $63.14B | $63.45B | (m) | 12 month · $8.87B | 12 month · 213.00M | $17.00M | $110.80B | (m) | (m) | 3.83B |
| 2019-09-29 | $468.00M | $87.10B | (m) | $-11.80B | $100.11B | $65.10B | $65.40B | (m) | 3 month · $0.00 9 month · $8.87B | (m) | $18.00M | $110.80B | (m) | (m) | (m) |
| 2019-08-05 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 33.50M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $468.00M | $86.96B | (m) | $-11.54B | $94.44B | $59.57B | $59.92B | (m) | 3 month · $0.00 6 month · $8.87B | (m) | $18.00M | $110.79B | (m) | (m) | (m) |
| 2019-03-31 | $468.00M | $86.64B | (m) | $-10.92B | $93.39B | $58.81B | $59.16B | (m) | 3 month · $8.87B | (m) | $19.00M | $110.78B | (m) | (m) | (m) |
| 2019-02-12 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 130.00M | (m) | (m) | (m) | (m) | (m) |
| 2019-01-01 | (m) | (m) | (m) | (m) | $89.57B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $467.00M | $86.25B | (m) | $-11.28B | $89.55B | $63.41B | $63.76B | (m) | 12 month · $12.20B | 12 month · 307.00M | $19.00M | $101.61B | (m) | (m) | 3.62B |
| 2018-09-30 | $466.00M | $85.83B | (m) | $-10.42B | $92.00B | $71.32B | $71.66B | (m) | 3 month · $1.10B 9 month · $7.17B | (m) | $20.00M | $96.57B | (m) | (m) | (m) |
| 2018-09-07 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 21.00M | (m) | (m) | (m) | (m) | (m) |
| 2018-07-01 | $465.00M | $84.90B | (m) | $-10.00B | $89.86B | $69.78B | $70.12B | (m) | 3 month · $0.00 6 month · $6.06B | (m) | $20.00M | $95.46B | (m) | (m) | (m) |
| 2018-04-01 | $465.00M | $84.60B | (m) | $-9.40B | $89.96B | $70.18B | $70.54B | (m) | 3 month · $6.06B | (m) | $21.00M | $95.46B | (m) | (m) | (m) |
| 2018-03-14 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 87.00M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-11 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 2 month · $8.20B | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-01-01 | (m) | (m) | (m) | $-10.23B | $86.47B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $464.00M | $84.28B | (m) | $-9.32B | $85.29B | $71.31B | $71.66B | (m) | 12 month · $5.00B | 12 month · 150.00M | $21.00M | $89.42B | (m) | (m) | 3.30B |
| 2017-10-01 | $463.00M | $83.83B | (m) | $-9.16B | $75.04B | $60.77B | $61.11B | (m) | (m) | (m) | $22.00M | $89.42B | (m) | (m) | (m) |
| 2017-07-02 | $463.00M | $83.37B | (m) | $-10.18B | $74.11B | $58.37B | $58.69B | (m) | (m) | (m) | $23.00M | $89.42B | (m) | (m) | (m) |
| 2017-04-02 | $463.00M | $83.11B | (m) | $-10.59B | $74.85B | $58.44B | $58.75B | (m) | (m) | (m) | $23.00M | $89.41B | (m) | (m) | (m) |
| 2016-12-31 | $461.00M | $82.69B | (m) | $-11.04B | $71.77B | $59.54B | $59.84B | (m) | 12 month · $5.00B | 12 month · 154.00M | $24.00M | $84.36B | (m) | (m) | 3.16B |
| 2016-10-02 | $461.00M | $82.53B | (m) | $-8.21B | $72.85B | $63.31B | $63.60B | (m) | (m) | (m) | $25.00M | $84.35B | (m) | (m) | (m) |
| 2016-07-03 | $461.00M | $82.14B | (m) | $-8.89B | $73.35B | $62.77B | $63.07B | (m) | (m) | (m) | $25.00M | $84.31B | (m) | (m) | (m) |
| 2016-06-20 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 18.00M | (m) | (m) | (m) | (m) | (m) |
| 2016-04-03 | $460.00M | $81.44B | (m) | $-9.52B | $74.97B | $63.07B | $63.35B | (m) | (m) | (m) | $26.00M | $84.31B | (m) | (m) | (m) |
| 2016-03-10 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 136.00M | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $459.00M | $81.02B | (m) | $-9.52B | $71.99B | $64.72B | $65.00B | (m) | 12 month · $6.16B | 12 month · 182.00M | $26.00M | $79.25B | (m) | (m) | 3.00B |
| 2015-09-27 | $459.00M | $80.76B | (m) | $-9.17B | $74.02B | $66.84B | $67.12B | (m) | (m) | (m) | $27.00M | $79.26B | (m) | (m) | (m) |
| 2015-07-13 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 5 month · 151.00M | (m) | (m) | (m) | (m) | (m) |
| 2015-06-28 | $458.00M | $80.41B | (m) | $-8.52B | $73.62B | $66.89B | $67.18B | (m) | (m) | (m) | $28.00M | $79.10B | (m) | (m) | (m) |
| 2015-03-29 | $458.00M | $80.00B | (m) | $-8.56B | $74.47B | $67.30B | $67.59B | (m) | (m) | (m) | $28.00M | $79.10B | (m) | (m) | (m) |
| 2015-02-11 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 151.00M | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $455.00M | $78.98B | (m) | $-7.32B | $72.18B | $71.30B | $71.62B | (m) | 12 month · $5.00B | 12 month · 165.00M | $29.00M | $73.02B | (m) | (m) | 2.82B |
| 2014-09-28 | $455.00M | $78.50B | (m) | $-3.47B | $74.29B | $77.99B | $78.31B | (m) | (m) | (m) | $30.00M | $71.82B | (m) | (m) | (m) |
| 2014-06-29 | $454.00M | $78.21B | (m) | $-3.15B | $71.63B | $76.63B | $76.96B | (m) | (m) | (m) | $31.00M | $70.53B | (m) | (m) | (m) |
| 2014-03-30 | $454.00M | $77.85B | (m) | $-3.39B | $72.03B | $77.77B | $78.07B | (m) | (m) | (m) | $32.00M | $69.20B | (m) | (m) | (m) |
| 2013-12-31 | $453.00M | $77.28B | (m) | $-3.27B | $69.73B | $76.31B | $76.62B | (m) | 12 month · $16.29B | 12 month · 563.00M | $33.00M | $67.92B | 12 month · $2.48B | 12 month · $145.00M | 2.65B |
| 2013-09-29 | $452.00M | $76.76B | (m) | $-6.38B | $70.38B | $77.97B | $78.35B | (m) | 9 month · $11.60B | (m) | $35.00M | $63.27B | (m) | (m) | (m) |
| 2013-06-30 | $451.00M | $76.41B | (m) | $-6.46B | $67.63B | $78.55B | $78.98B | (m) | 6 month · $7.90B | (m) | $36.00M | $59.52B | (m) | (m) | (m) |
| 2013-03-31 | $450.00M | $75.78B | (m) | $-6.16B | $56.97B | $82.25B | $82.83B | (m) | (m) | (m) | $38.00M | $44.83B | (m) | (m) | (m) |
| 2012-12-31 | $448.00M | $72.61B | (m) | $-5.95B | $54.24B | $81.26B | $81.68B | (m) | 12 month · $8.23B | 12 month · 349.00M | $39.00M | $40.12B | (m) | (m) | 1.68B |
| 2012-09-30 | $447.00M | $72.32B | (m) | $-5.65B | $51.26B | $81.70B | $82.11B | (m) | (m) | (m) | $41.00M | $36.70B | (m) | (m) | (m) |
| 2012-07-01 | $447.00M | $72.03B | (m) | $-6.01B | $47.90B | $79.55B | $79.96B | (m) | (m) | (m) | $42.00M | $34.86B | (m) | (m) | (m) |
| 2012-04-01 | $446.00M | $71.79B | (m) | $-3.62B | $48.12B | $83.26B | $83.68B | (m) | (m) | (m) | $43.00M | $33.52B | (m) | (m) | (m) |
| 2011-12-31 | $445.00M | $71.42B | (m) | $-4.13B | $46.21B | $82.19B | $82.62B | (m) | 12 month · $9.00B 78 month · $28.00B | 12 month · 459.00M 78 month · 1.20B | $45.00M | $31.80B | (m) | (m) | 1.33B |
| 2011-10-02 | $445.00M | $71.23B | (m) | $-1.21B | $48.12B | $90.05B | $90.53B | (m) | (m) | (m) | $46.00M | $28.59B | (m) | (m) | (m) |
| 2011-07-03 | $445.00M | $71.09B | (m) | $-952.00M | $44.32B | $88.48B | $88.96B | (m) | (m) | (m) | $47.00M | $26.47B | (m) | (m) | (m) |
| 2011-04-03 | $444.00M | $70.92B | (m) | $-2.06B | $44.93B | $90.07B | $90.53B | (m) | (m) | (m) | $49.00M | $24.21B | (m) | (m) | (m) |
| 2010-12-31 | $444.00M | $70.76B | (m) | $-3.44B | $42.72B | $87.81B | $88.27B | (m) | 12 month · $1.00B | 12 month · 61.00M | $52.00M | $22.71B | (m) | (m) | 864.00M |
| 2010-10-03 | $443.00M | $70.68B | (m) | $-3.70B | $42.87B | $87.64B | $88.07B | (m) | (m) | (m) | $54.00M | $22.71B | (m) | (m) | (m) |
| 2010-07-04 | $443.00M | $70.57B | (m) | $-4.41B | $42.01B | $86.44B | $86.88B | (m) | (m) | (m) | $56.00M | $22.21B | (m) | (m) | (m) |
| 2010-04-04 | $443.00M | $70.46B | (m) | $-1.94B | $42.43B | $89.66B | $90.08B | (m) | (m) | (m) | $58.00M | $21.70B | (m) | (m) | (m) |
| 2009-12-31 | $443.00M | $70.50B | (m) | $552.00M | $40.43B | $90.01B | $90.45B | (m) | 12 month · $0.00 | (m) | $61.00M | $21.63B | (m) | (m) | 799.00M |
| 2009-09-27 | $443.00M | $70.37B | (m) | $-1.90B | $54.84B | $66.16B | $66.25B | (m) | (m) | (m) | $64.00M | $57.36B | (m) | (m) | (m) |
| 2009-06-28 | $443.00M | $70.31B | (m) | $-2.08B | $51.97B | $63.04B | $63.23B | (m) | (m) | (m) | $66.00M | $57.36B | (m) | (m) | (m) |
| 2008-12-31 | $443.00M | $70.28B | (m) | $-4.57B | $49.14B | $57.56B | $57.74B | (m) | 12 month · $-500.00M | (m) | $73.00M | $57.39B | (m) | (m) | 2.12B |
| 2007-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $65.12B | (m) | 12 month · $9.99B | (m) | (m) | (m) | (m) | (m) | (m) |
| 2006-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $71.43B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |